Literature DB >> 21936519

Syntheses and cellular investigations of 17(3)-, 15(2)-, and 13(1)-amino acid derivatives of chlorin e(6).

R G Waruna Jinadasa1, Xiaoke Hu, M Graça H Vicente, Kevin M Smith.   

Abstract

A series of amino acid conjugates of chlorin e(6), containing lysine or aspartic acid residues in positions 17(3), 15(2), or 13(1) of the macrocycle were synthesized and investigated as photosensitizers for photodynamic therapy of tumors. All three regioisomers were synthesized in good yields and in five steps or less from pheophytin a (1). In vitro investigations using human carcinoma HEp2 cells show that the 15(2)-lysyl regioisomers accumulate the most within cells, and the most phototoxic are the 13(1) regioisomers. The main determinant of biological efficacy appears to be the conjugation site, probably because of molecular conformation. Molecular modeling investigations reveal that the 17(3)-substituted chlorin e(6) conjugates are L-shaped, the 15(2) and 13(1) regioisomers assume extended conformations, and the 13(1) derivatives are nearly linear. It is hypothesized that the 13(1)-aspartylchlorin e(6) conjugate may be a more efficient photosensitizer for PDT than the commercial currently used 15(2) derivative.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936519      PMCID: PMC3208129          DOI: 10.1021/jm2005139

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  33 in total

1.  Remote intermolecular "heavy-atom effect": spin-orbit coupling across the wall of a hemicarcerand.

Authors:  Z S Romanova; K Deshayes; P Piotrowiak
Journal:  J Am Chem Soc       Date:  2001-03-14       Impact factor: 15.419

2.  Photodynamic effect of novel chlorin e6 derivatives on a single nerve cell.

Authors:  A B Uzdensky; O Y Dergacheva; A A Zhavoronkova; A V Reshetnikov; G V Ponomarev
Journal:  Life Sci       Date:  2004-03-12       Impact factor: 5.037

3.  Influence of the number and distribution of NLS peptides on the photosensitizing activity of multimeric porphyrin-NLS.

Authors:  Martha Sibrian-Vazquez; Timothy J Jensen; M Graça H Vicente
Journal:  Org Biomol Chem       Date:  2010-01-14       Impact factor: 3.876

4.  Photosensitizers in clinical PDT.

Authors:  Ron R Allison; Gordon H Downie; Rosa Cuenca; Xin-Hua Hu; Carter Jh Childs; Claudio H Sibata
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-05       Impact factor: 3.631

5.  Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.

Authors:  Ulas Sunar; Daniel Rohrbach; Nestor Rigual; Erin Tracy; Ken Keymel; Michele T Cooper; Heinz Baumann; Barbara H Henderson
Journal:  Opt Express       Date:  2010-07-05       Impact factor: 3.894

Review 6.  Talaporfin sodium.

Authors:  S Wang; Elizabeth Bromley; Leon Xu; James C Chen; Llew Keltner
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

7.  Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors.

Authors:  G A Kostenich; I N Zhuravkin; E A Zhavrid
Journal:  J Photochem Photobiol B       Date:  1994-03       Impact factor: 6.252

8.  Novel boronated chlorin e6-based photosensitizers: synthesis, binding to albumin and antitumour efficacy.

Authors:  Valentina A Ol'shevskaya; Roza G Nikitina; Arina N Savchenko; Marina V Malshakova; Alexander M Vinogradov; Galina V Golovina; Dmitry V Belykh; Alexander V Kutchin; Mikhail A Kaplan; Valery N Kalinin; Vladimir A Kuzmin; Alexander A Shtil
Journal:  Bioorg Med Chem       Date:  2008-12-24       Impact factor: 3.641

9.  Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.

Authors:  J Trachtenberg; A Bogaards; R A Weersink; M A Haider; A Evans; S A McCluskey; A Scherz; M R Gertner; C Yue; S Appu; A Aprikian; J Savard; B C Wilson; M Elhilali
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

10.  Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates.

Authors:  U Schmidt-Erfurth; H Diddens; R Birngruber; T Hasan
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  6 in total

1.  Photoactive fluoropolymer surfaces that release sensitizer drug molecules.

Authors:  Goutam Ghosh; Mihaela Minnis; Ashwini A Ghogare; Inna Abramova; Keith A Cengel; Theresa M Busch; Alexander Greer
Journal:  J Phys Chem B       Date:  2015-02-26       Impact factor: 2.991

2.  Chlorin e6 131:152-Anhydride: A Key Intermediate in Conjugation Reactions of Chlorin e6.

Authors:  Hui Chen; R G Waruna Jinadasa; Lijuan Jiao; Frank R Fronczek; Alex L Nguyen; Kevin M Smith
Journal:  European J Org Chem       Date:  2015-06

3.  Syntheses and cellular investigations of di-aspartate and aspartate-lysine chlorin e(6) conjugates.

Authors:  R G Waruna Jinadasa; Zehua Zhou; M Graça H Vicente; Kevin M Smith
Journal:  Org Biomol Chem       Date:  2015-12-03       Impact factor: 3.876

4.  Syntheses and PDT activity of new mono- and di-conjugated derivatives of chlorin e6.

Authors:  Hui Chen; Stewart W Humble; R G Waruna Jinadasa; Zehua Zhou; Alex L Nguyen; M Graça H Vicente; Kevin M Smith
Journal:  J Porphyr Phthalocyanines       Date:  2017 Apr-Jun       Impact factor: 1.811

5.  Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer.

Authors:  Ravindra R Cheruku; Joseph Cacaccio; Farukh A Durrani; Walter A Tabaczynski; Ramona Watson; Kevin Siters; Joseph R Missert; Erin C Tracy; Mykhaylo Dukh; Khurshid Guru; Richard C Koya; Pawel Kalinski; Heinz Baumann; Ravindra K Pandey
Journal:  J Med Chem       Date:  2021-01-05       Impact factor: 8.039

6.  Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines.

Authors:  Elnaz Yaghini; Ruggero Dondi; Kunal M Tewari; Marilena Loizidou; Ian M Eggleston; Alexander J MacRobert
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.